These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Platelets and foam cells in the evolution of atherosclerosis. Histological and immunohistological studies of human lesions. Sevitt S Atherosclerosis; 1986 Aug; 61(2):107-15. PubMed ID: 2428379 [TBL] [Abstract][Full Text] [Related]
9. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Zhou J; Lhoták S; Hilditch BA; Austin RC Circulation; 2005 Apr; 111(14):1814-21. PubMed ID: 15809369 [TBL] [Abstract][Full Text] [Related]
10. Role of platelets in cholesteryl ester formation by U-937 cells. Mendelsohn ME; Loscalzo J J Clin Invest; 1988 Jan; 81(1):62-8. PubMed ID: 3335643 [TBL] [Abstract][Full Text] [Related]
11. Platelet-enhanced apolipoprotein E production by human macrophages: a possible role in atherosclerosis. Takagi Y; Dyer CA; Curtiss LK J Lipid Res; 1988 Jul; 29(7):859-67. PubMed ID: 3411246 [TBL] [Abstract][Full Text] [Related]
12. Pitavastatin inhibits remnant lipoprotein-induced macrophage foam cell formation through ApoB48 receptor-dependent mechanism. Kawakami A; Tani M; Chiba T; Yui K; Shinozaki S; Nakajima K; Tanaka A; Shimokado K; Yoshida M Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):424-9. PubMed ID: 15591219 [TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis and molecular pathology: mechanisms of cholesteryl ester accumulation in foam cells and extracellular space of atherosclerotic lesions. Takano T; Mineo C J Pharmacobiodyn; 1990 Jul; 13(7):385-413. PubMed ID: 2290125 [TBL] [Abstract][Full Text] [Related]
14. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. Moore KJ; Kunjathoor VV; Koehn SL; Manning JJ; Tseng AA; Silver JM; McKee M; Freeman MW J Clin Invest; 2005 Aug; 115(8):2192-201. PubMed ID: 16075060 [TBL] [Abstract][Full Text] [Related]
15. Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Ouimet M; Marcel YL Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):575-81. PubMed ID: 22207731 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of macrophage-derived foam cells isolated from atherosclerotic lesions of rabbits. Naito M; Nomura H; Esaki T; Iguchi A Atherosclerosis; 1997 Dec; 135(2):241-7. PubMed ID: 9430374 [TBL] [Abstract][Full Text] [Related]
17. Uptake of dexamethasone incorporated into liposomes by macrophages and foam cells and its inhibitory effect on cellular cholesterol ester accumulation. Chono S; Morimoto K J Pharm Pharmacol; 2006 Sep; 58(9):1219-25. PubMed ID: 16945180 [TBL] [Abstract][Full Text] [Related]
18. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. Cullen P; Cignarella A; Brennhausen B; Mohr S; Assmann G; von Eckardstein A J Clin Invest; 1998 Apr; 101(8):1670-7. PubMed ID: 9541497 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone. Yang L; Yang JB; Chen J; Yu GY; Zhou P; Lei L; Wang ZZ; Cy Chang C; Yang XY; Chang TY; Li BL Cell Res; 2004 Aug; 14(4):315-23. PubMed ID: 15353128 [TBL] [Abstract][Full Text] [Related]
20. Role of platelet secretory products in modified lipoprotein metabolism in macrophages. Hayashi T; Naito M; Kuzuya M; Funaki C; Tateishi T; Asai K; Kuzuya F Artery; 1989; 16(5):248-62. PubMed ID: 2764730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]